HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006.

Abstract
This study sought to determine the microbiology of recurrent acute otitis media (AOM) and AOM treatment failure (AOMTF) in the context of widespread use of heptavalent pneumococcal conjugate vaccine (PCV7). In this retrospective cohort study, 244 AOM isolates obtained by tympanocentesis during 3 respiratory seasons--2003-2004 (n = 126), 2004-2005 (n = 52), 2005-2006 (n = 66)--from three geographically diverse pediatric populations were compared. Most isolates were from children less than 2 years old, who had received PCV7. For the 3 seasons the proportion of Streptococcus pneumoniae isolates was 35%, 35%, and 46% and for Haemophilus influenzae was 55%, 58%, and 39%, respectively (change in trend, P = .09). A total of 37%, 39%, and 50% of S. pneumoniae were penicillin nonsusceptible (PNSP) and 48%, 67%, and 50% of H. influenzae produced beta-lactamase, respectively. Although H. influenzae remains the most frequently isolated pathogen in children with AOMTF or recurrent AOM, S. pneumoniae that are PNSP are reemerging as important organisms.
AuthorsMichael E Pichichero, Janet R Casey, Alejandro Hoberman, Richard Schwartz
JournalClinical pediatrics (Clin Pediatr (Phila)) Vol. 47 Issue 9 Pg. 901-6 (Nov 2008) ISSN: 0009-9228 [Print] United States
PMID18559884 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Heptavalent Pneumococcal Conjugate Vaccine
  • Meningococcal Vaccines
  • Pneumococcal Vaccines
Topics
  • Acute Disease
  • Chi-Square Distribution
  • Female
  • Haemophilus influenzae (isolation & purification)
  • Heptavalent Pneumococcal Conjugate Vaccine
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Meningococcal Vaccines (administration & dosage)
  • Otitis Media (immunology, microbiology, prevention & control)
  • Pneumococcal Vaccines (administration & dosage)
  • Recurrence
  • Retrospective Studies
  • Streptococcus pneumoniae (isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: